Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.41%
0%
-5.41%
6 Months
31.03%
0%
31.03%
1 Year
48.8%
0%
48.8%
2 Years
49.6%
0%
49.6%
3 Years
-28.19%
0%
-28.19%
4 Years
-65.86%
0%
-65.86%
5 Years
-54.43%
0%
-54.43%
Pharmaron Beijing Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.77%
EBIT Growth (5y)
14.32%
EBIT to Interest (avg)
18.63
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.59
Tax Ratio
17.61%
Dividend Payout Ratio
19.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.47%
ROE (avg)
12.92%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.40
EV to EBIT
4.45
EV to EBITDA
2.76
EV to Capital Employed
0.50
EV to Sales
0.67
PEG Ratio
NA
Dividend Yield
1.05%
ROCE (Latest)
11.28%
ROE (Latest)
9.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
3,572.00
3,288.30
8.63%
Operating Profit (PBDIT) excl Other Income
838.30
779.50
7.54%
Interest
54.30
46.90
15.78%
Exceptional Items
33.70
-13.70
345.99%
Consolidate Net Profit
402.50
299.00
34.62%
Operating Profit Margin (Excl OI)
142.60%
138.00%
0.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.63% vs -12.08% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 34.62% vs -19.84% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
13,309.70
12,749.50
4.39%
Operating Profit (PBDIT) excl Other Income
3,101.30
2,977.60
4.15%
Interest
264.20
201.30
31.25%
Exceptional Items
570.40
57.20
897.20%
Consolidate Net Profit
1,858.50
1,747.90
6.33%
Operating Profit Margin (Excl OI)
139.70%
146.10%
-0.64%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.39% vs 6.79% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 6.33% vs 11.20% in Dec 2023
About Pharmaron Beijing Co., Ltd. 
Pharmaron Beijing Co., Ltd.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






